Early Enteral Feeding and Clinical Outcomes in ICU Patients
EEFP
Effectiveness of an Early Enteral Feeding Protocol on Clinical Outcomes in Critically Ill Patients: A Quasi-experimental Study
1 other identifier
interventional
80
1 country
1
Brief Summary
This study evaluated the effectiveness of an early enteral feeding protocol in critically ill adult patients admitted to an Intensive Care Unit (ICU). The intervention involved initiating enteral nutrition within 24-48 hours of ICU admission. Clinical outcomes such as ICU length of stay, ventilator dependency, and selected laboratory values were compared between patients who received early enteral feeding and those who received standard nutritional care. The study was conducted at Jenin Governmental Hospital in Palestine between January and April 2024, with 80 adult participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2024
CompletedFirst Submitted
Initial submission to the registry
August 6, 2025
CompletedFirst Posted
Study publicly available on registry
August 20, 2025
CompletedAugust 20, 2025
August 1, 2025
4 months
August 6, 2025
August 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Length of ICU Stay (in days)
Duration of patient stay in the intensive care unit, measured in full days from admission to discharge.
Through ICU discharge, up to 7 days
Secondary Outcomes (8)
Glasgow Coma Scale (GCS) Score
Daily for up to 7 days.
Hemoglobin Level (g/dL)
Day 1 and Day 7 of ICU stay
Bicarbonate (HCO₃) Level (mEq/L)
Day 1 and Day 7 of ICU stay
Platelet Count (×10³/μL)
Day 1 and Day 7 of ICU stay
Calcium Level (mg/dL)
Day 1 and Day 7 of ICU stay
- +3 more secondary outcomes
Study Arms (2)
Early Enteral Feeding Protocol
EXPERIMENTALParticipants in this group received early enteral nutrition initiated within 24-48 hours of ICU admission, based on a structured feeding protocol. The protocol followed international guidelines (ASPEN/ESPEN) and was implemented by ICU staff with training and monitoring support.
Standard Nutritional Care
OTHERParticipants in this group received standard ICU nutritional care without the implementation of the early enteral feeding protocol. Feeding initiation and type were left to physician discretion based on clinical judgment and routine hospital practices.
Interventions
Early enteral nutrition was initiated within 24-48 hours of ICU admission based on a structured protocol aligned with ASPEN and ESPEN guidelines. The protocol defined target caloric goals, methods of tube feeding initiation, rate advancement, and monitoring procedures. Nurses and ICU staff were trained in protocol implementation. The goal was to optimize nutrition early in critical illness to improve clinical outcomes such as ICU length of stay, ventilator dependence, and physiological stability.
Patients in the control group received standard nutritional care per routine hospital practices. Initiation and progression of feeding were left to the discretion of the attending physician and nursing staff, without the use of a structured protocol or defined early feeding timeline.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years and older
- Admitted to the ICU and eligible for enteral feeding
- Expected to stay in the ICU for more than 48 hours
- Able to initiate enteral feeding within 24-48 hours of ICU admission
- Informed consent obtained from the patient or legal guardian
You may not qualify if:
- Pregnant or lactating women
- Patients with gastrointestinal bleeding or obstruction
- Patients undergoing gastrointestinal surgery or with short bowel syndrome
- Diagnosed with COVID-19 during admission
- End-of-life care patients or those with do-not-resuscitate (DNR) orders
- Refusal to participate or withdrawal of consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jenin Governmental Hospital
Jenin, 00970, Palestinian Territories
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hussein Mahameed, Master
Arab American University (Palestine)
- STUDY CHAIR
Sajed Ghawadra, PhD
Arab American University (Palestine)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- This was an open-label study. Neither the care providers nor the participants were blinded to the intervention assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Faculty Member, Arab American University
Study Record Dates
First Submitted
August 6, 2025
First Posted
August 20, 2025
Study Start
January 1, 2024
Primary Completion
April 30, 2024
Study Completion
April 30, 2024
Last Updated
August 20, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
The individual participant data (IPD) collected during this study will not be shared publicly due to ethical and legal restrictions. The study involved critically ill patients in an intensive care setting, and data sharing was not included in the original informed consent or ethics approval. Ensuring patient confidentiality and privacy remains a top priority.